Viewing Study NCT02577094


Ignite Creation Date: 2025-12-25 @ 1:38 AM
Ignite Modification Date: 2025-12-31 @ 7:36 PM
Study NCT ID: NCT02577094
Status: WITHDRAWN
Last Update Posted: 2017-01-19
First Post: 2015-10-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Testing a Reduced Conditioning Regimen FB2A2 Preceded by a Fractionated Radio-immunotherapy (RIT) With 90Y-Epratuzumab Before Allogeneic Stem Cell Transplantation for Patients With Lymphocyte B CD22 Positive Acute Lymphoblastic Leukemia
Sponsor: Nantes University Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphocyte B CD22 Positive Acute Lymphoblastic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CD22 positive- lymphoblastic leukemia-RIT-Yttrium View